C. Puccio, M.D., and Robert G. Lerner, M.D.

Dr. Puccio is Assistant Professor of Medicine at New York Medical College in the Division of Neoplastic Disease and has published extensively on solid tumor clinical trials. Dr. Puccio reports no commercial conflict of interest. In the past three years, Dr. Lerner has served as a consultant for RPR, and has served on the Speakers' Bureau for Pharmacia & Upjohn.

Release Date: 09/28/2002
Termination Date: 09/28/2005

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Discuss the controversy concerning screening for prostate cancer with prostate specific antigen
• Recognize men at high risk for spinal cord compression from prostate cancer
• Discuss emergency diagnostic and therapeutic management of spinal cord compression due to prostate cancer
• Recognize the risk of tumor flare associated with the use of a luteinizing hormone releasing hormone agonist.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity